Pulmonx (LUNG) Net Margin (2019 - 2025)

Pulmonx (LUNG) reported Net Margin of 64.91% for Q3 2025, up 451.0% year-over-year from 11.78% in Q3 2024, and down 1.91% quarter-over-quarter from 63.69% in Q2 2025.

Pulmonx (LUNG) Net Margin (2019 - 2025) Analysis & Trends

Pulmonx (LUNG) has 7 years of Net Margin data on file, last reported at 64.91% in Q3 2025.

  • Net Margin for Q3 2025 came in at 64.91%, up 451.0% year-over-year; the trailing twelve-month figure through Sep 2025 was 61.9% (up 1017.0% YoY), and the FY2024 annual result was 67.3%, up 2129.0% from the prior year.
  • Net Margin fell to 64.91% in Q3 2025 per LUNG's latest filing, from 63.69% in the prior quarter.
  • Over five years, Net Margin peaked at 55.44% in Q4 2024 and troughed at 147.07% in Q1 2022.
  • A 5-year average of 88.79% and a median of 84.57% in 2023 frame the typical range for Net Margin.
  • On a YoY basis, Net Margin climbed as much as 21926 bps in 2021 and fell as far as 5224 bps in 2021.
  • A 5-year view of Net Margin shows it stood at 94.81% in 2021, then grew by 2 bps to 92.64% in 2022, then rose by 22 bps to 72.16% in 2023, then gained by 23 bps to 55.44% in 2024, then decreased by 17 bps to 64.91% in 2025.
  • Business Quant data shows LUNG's Net Margin at 64.91% in Q3 2025, 63.69% in Q2 2025, and 63.95% in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 9.65%
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 12.38%
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 12.75%
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 25.77%
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.00%
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 16.74%
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 8.01%
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Pulmonx 54.38 Mn -15.37 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 -64.91%
Jun 30, 2025 -63.69%
Mar 31, 2025 -63.95%
Dec 31, 2024 -55.44%
Sep 30, 2024 -69.42%
Jun 30, 2024 -73.82%
Mar 31, 2024 -72.92%
Dec 31, 2023 -72.16%
Sep 30, 2023 -84.57%
Jun 30, 2023 -94.19%
Mar 31, 2023 -109.12%
Dec 31, 2022 -92.64%
Sep 30, 2022 -104.96%
Jun 30, 2022 -104.95%
Mar 31, 2022 -147.07%
Dec 31, 2021 -94.81%
Sep 30, 2021 -76.77%
Jun 30, 2021 -106.22%
Mar 31, 2021 -135.35%
Dec 31, 2020 -94.50%